Should morbidity replace mortality as an endpoint for clinical trials in intensive care?

[1]  R. Mason,et al.  Identification of futility in intensive care , 1994, The Lancet.

[2]  C. Sprung,et al.  Why have new effective therapies for sepsis not been developed? , 1994, Critical care medicine.

[3]  B. Thompson,et al.  Renal-dose dopamine: a Siren song? , 1994, The Lancet.

[4]  B. Nyström.  Impact of handwashing on mortality in intensive care: examination of the evidence. , 1994, Infection control and hospital epidemiology.

[5]  A. Cross.  Antiendotoxin Antibodies: A Dead End? , 1994, Annals of Internal Medicine.

[6]  C. Hinds,et al.  Elevation of systemic oxygen delivery in the treatment of critically ill patients. , 1994, The New England journal of medicine.

[7]  U. Grohmann,et al.  Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. , 1994, Journal of immunology.

[8]  C J Fisher,et al.  The clinical evaluation of new drugs for sepsis. A prospective study design based on survival analysis. , 1993, JAMA.

[9]  G. Tytgat,et al.  Tumour-necrosis-factor antibody treatment in Crohn's disease , 1993, The Lancet.

[10]  D. Kwiatkowski,et al.  Anti-TNF therapy inhibits fever in cerebral malaria. , 1993, The Quarterly journal of medicine.

[11]  T C Chalmers,et al.  Cumulative meta-analysis of therapeutic trials for myocardial infarction. , 1992, The New England journal of medicine.

[12]  H. Valkenburg,et al.  Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis , 1992, The Lancet.

[13]  R. Smith,et al.  Where is the wisdom...? , 1991, BMJ.

[14]  H. Langstein,et al.  Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis. , 1991, The Journal of clinical investigation.

[15]  T. Noseworthy,et al.  National estimates of intensive care utilization and costs: Canada and the United States. , 1990, Critical care medicine.

[16]  W. Shoemaker.  Use and abuse of the balloon tip pulmonary artery (Swan-Ganz) catheter: are patients getting their money's worth? , 1990, Critical Care Medicine.

[17]  G. Guyatt,et al.  A new measure of health status for clinical trials in inflammatory bowel disease. , 1989, Gastroenterology.

[18]  T. Clemmer,et al.  A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. , 1987, The New England journal of medicine.

[19]  S. Hoffman,et al.  Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone. , 1984, The New England journal of medicine.

[20]  R. Deyo,et al.  Measuring Functional Outcomes in Chronic Disease: A Comparison of Traditional Scales and a Self- Administered Health Status Questionnaire in Patients With Rheumatoid Arthritis , 1983, Medical care.

[21]  S. Gorbach,et al.  Effect of Preoperative Neornycin‐Erythromycin Intestinal Preparation on the Incidence of Infectious Complications Following Colon Surgery , 1973, Annals of surgery.